|
Figure 5 Immunofluorescence Validation of PGAM5 in Human LiverImmunofluorescent analysis of 4% paraformaldehyde-fixed human liver labeling PGAM5 with 9517 at 20 &956,g/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue). |
|
Figure 6 Immunofluorescence Validation of PGAM5 in Mouse TestisImmunofluorescent analysis of 4% paraformaldehyde-fixed mouse testis labeling PGAM5 with 9517 at 10 &956,g/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue). |
|
Figure 7 Immunofluorescence Validation of PGAM5 in Rat TestisImmunofluorescent analysis of 4% paraformaldehyde-fixed rat testis labeling PGAM5 with 9517 at 20 &956,g/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue). |
|
Figure 1 Western Blot Validation in Mouse and Rat Cell Lines Loading: 15 &956,g of lysates per lane. Antibodies: PGAM5, 9517 0.5 &956,g/mL, 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10,000 dilution. |
|
Figure 2 Western Blot Validation in Human Cell Lines Loading: 15 &956,g of lysates per lane. Antibodies: PGAM5, 9517 0.5 &956,g/mL, 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10,000 dilution. |
|
Figure 3 Western Blot Validation in Mouse Tissues Loading: 15 &956,g of lysates per lane. Antibodies: PGAM5, 9517 0.5 &956,g/mL, 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10,000 dilution. |
|
Figure 4 Western Blot Validation in Rat Tissues Loading: 15 &956,g of lysates per lane. Antibodies: PGAM5, 9517 0.5 &956,g/mL, 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10,000 dilution. |